|
Showing the most relevant articles for your search:AMEX:ILI | Date | Time | Source | Headline | Symbol | Company | | 08/12/2010 | 4:07PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ILI | Interleukin Genetics, |
| 08/05/2010 | 4:01PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:ILI | Interleukin Genetics, |
| 08/05/2010 | 8:49AM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:ILI | Interleukin Genetics, |
| 08/05/2010 | 7:02AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 07/21/2010 | 4:30PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 06/25/2010 | 5:06PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 06/21/2010 | 6:31AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 05/13/2010 | 4:06PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ILI | Interleukin Genetics, |
| 05/05/2010 | 6:02AM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | AMEX:ILI | Interleukin Genetics, |
| 04/30/2010 | 7:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 04/30/2010 | 7:06PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:ILI | Interleukin Genetics, |
| 04/30/2010 | 4:36PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 04/30/2010 | 1:15PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | AMEX:ILI | Interleukin Genetics, |
| 04/13/2010 | 5:04PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | AMEX:ILI | Interleukin Genetics, |
| 04/08/2010 | 4:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 04/08/2010 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 04/05/2010 | 4:35PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | AMEX:ILI | Interleukin Genetics, |
| 04/01/2010 | 4:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 03/25/2010 | 4:13PM | Edgar (US Regulatory) | Annual Report (10-K) | AMEX:ILI | Interleukin Genetics, |
| 03/19/2010 | 4:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 03/10/2010 | 5:11PM | Edgar (US Regulatory) | Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP) | AMEX:ILI | Interleukin Genetics, |
| 03/09/2010 | 9:46AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | AMEX:ILI | Interleukin Genetics, |
| 03/05/2010 | 2:52PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | AMEX:ILI | Interleukin Genetics, |
| 03/03/2010 | 2:04PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 03/01/2010 | 5:00PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 02/19/2010 | 5:03PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | AMEX:ILI | Interleukin Genetics, |
| 02/04/2010 | 7:00AM | PR Newswire (US) | Interleukin Genetics to Present at the 12th Annual BIO CEO Conference | AMEX:ILI | |
| 02/03/2010 | 4:34PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:ILI | Interleukin Genetics, |
| 02/02/2010 | 5:01PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 01/25/2010 | 4:17PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
|
Showing the most relevant articles for your search:AMEX:ILI |
|